ArticleBMC cancer2020

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.

Hyera Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.